Oral Session 1-13A MPN: Basic (1)

[OS1-13A-2] Elotuzumab suppresses fibrocyte differentiation as a potent therapeutic agent for myelofibrosis

Takaaki Maekawa¹, Yukiko Osawa¹, Takehiro Sone¹, Kohei Takada¹, Hiraku Ogata¹, Keita Saito¹, Takuya Izumi¹, Shigeki Nagao¹, Kosuke Takano¹, Yosuke Okada¹, Noriaki Tachi¹, Masahiro Teramoto¹, Toshikuni Kawamura¹, Toshikatsu Horiuchi¹, Reina Saga¹, Shoichiro Kato¹, Ayaka Kobayashi¹, Shinichi Kobayashi¹, Ken Sato¹, Shinya Suzu², Fumihiko Kimura¹ (1.Hematol., N.D.M.C., Saitama, Japan, 2.Center for AIDS Res., Kumamoto Univ., Kumamoto, Japan)